Tumor-agnostic drug development: Perspectives from academia, industry, regulators, payors and patients

Name: Tumor-agnostic drug development: Perspectives from academia, industry, regulators, payors and patients
Start: 2027-09-17T13:30
End: 2027-09-17T15:00
Location: Fira Gran Via

ESMO Congress · 17 September 2027 · 13:30–15:00 · Salamanca Auditorium - Hall 5

Tumor-agnostic drug development: Perspectives from academia, industry, regulators, payors and patients was a session at ESMO Congress on 17 September 2027 in Barcelona, with 2 speakers on record.

Speakers

Bettina Ryll — Speaker Melanoma Patient Network Europe MPNE
Emile E. Voest — Chair NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital